BACKGROUND: The HIV pandemic disseminated globally from Central West Africa, beginning in the second half of the twentieth century. To elucidate the virologic origins of the pandemic, a cross-sectional study was conducted of the genetic diversity of HIV-1 strains in villagers in 14 remote locations in Cameroon and in hospitalized and STI patients. DNA extracted from PBMC was PCR amplified from HIV(+) subjects. Partial pol amplicons (N = 164) and nearly full virus genomes (N = 78) were sequenced. Among the 3956 rural villagers studied, the prevalence of HIV infection was 4.9%; among the hospitalized and clinic patients, it was 8.6%. RESULTS: Virus genotypes fell into two distinctive groups. A majority of the genotyped strains (109/164) were the circulating recombinant form (CRF) known to be endemic in West Africa and Central West Africa, CRF02_AG. The second most common genetic form (9/164) was the recently described CRF22_01A1, and the rest were a collection of 4 different subtypes (A2, D, F2, G) and 6 different CRFs (-01, -11, -13, -18, -25, -37). Remarkably, 10.4% of HIV-1 genomes detected (17/164) were heretofore undescribed unique recombinant forms (URF) present in only a single person. Nearly full genome sequencing was completed for 78 of the viruses of interest. HIV genetic diversity was commonplace in rural villages: 12 villages each had at least one newly detected URF, and 9 villages had two or more. CONCLUSIONS: These results show that while CRF02_AG dominated the HIV strains in the rural villages, the remainder of the viruses had tremendous genetic diversity. Between the trans-species transmission of SIVcpz and the dispersal of pandemic HIV-1, there was a time when we hypothesize that nascent HIV-1 was spreading, but only to a limited extent, recombining with other local HIV-1, creating a large variety of recombinants. When one of those recombinants began to spread widely (i.e. became epidemic), it was recognized as a subtype. We hypothesize that the viruses in these remote Cameroon villages may represent that pre-epidemic stage of viral evolution.
BACKGROUND: The HIV pandemic disseminated globally from Central West Africa, beginning in the second half of the twentieth century. To elucidate the virologic origins of the pandemic, a cross-sectional study was conducted of the genetic diversity of HIV-1 strains in villagers in 14 remote locations in Cameroon and in hospitalized and STI patients. DNA extracted from PBMC was PCR amplified from HIV(+) subjects. Partial pol amplicons (N = 164) and nearly full virus genomes (N = 78) were sequenced. Among the 3956 rural villagers studied, the prevalence of HIV infection was 4.9%; among the hospitalized and clinic patients, it was 8.6%. RESULTS: Virus genotypes fell into two distinctive groups. A majority of the genotyped strains (109/164) were the circulating recombinant form (CRF) known to be endemic in West Africa and Central West Africa, CRF02_AG. The second most common genetic form (9/164) was the recently described CRF22_01A1, and the rest were a collection of 4 different subtypes (A2, D, F2, G) and 6 different CRFs (-01, -11, -13, -18, -25, -37). Remarkably, 10.4% of HIV-1 genomes detected (17/164) were heretofore undescribed unique recombinant forms (URF) present in only a single person. Nearly full genome sequencing was completed for 78 of the viruses of interest. HIV genetic diversity was commonplace in rural villages: 12 villages each had at least one newly detected URF, and 9 villages had two or more. CONCLUSIONS: These results show that while CRF02_AG dominated the HIV strains in the rural villages, the remainder of the viruses had tremendous genetic diversity. Between the trans-species transmission of SIVcpz and the dispersal of pandemic HIV-1, there was a time when we hypothesize that nascent HIV-1 was spreading, but only to a limited extent, recombining with other local HIV-1, creating a large variety of recombinants. When one of those recombinants began to spread widely (i.e. became epidemic), it was recognized as a subtype. We hypothesize that the viruses in these remote Cameroon villages may represent that pre-epidemic stage of viral evolution.
Authors: Ka-Cheung Luk; Vera Holzmayer; Nicaise Ndembi; Priscilla Swanson; Catherine A Brennan; Charlotte Ngansop; Dora Mbanya; Lazare Kaptué; Lutz Gürtler; Sushil G Devare; John Hackett Journal: AIDS Res Hum Retroviruses Date: 2008-10 Impact factor: 2.205
Authors: Fran Van Heuverswyn; Yingying Li; Elizabeth Bailes; Cecile Neel; Benedicte Lafay; Brandon F Keele; Katharina S Shaw; Jun Takehisa; Matthias H Kraus; Severin Loul; Christelle Butel; Florian Liegeois; Bienvenue Yangda; Paul M Sharp; Eitel Mpoudi-Ngole; Eric Delaporte; Beatrice H Hahn; Martine Peeters Journal: Virology Date: 2007-07-24 Impact factor: 3.616
Authors: Catherine A Brennan; Pierre Bodelle; Ruthie Coffey; Sushil G Devare; Alan Golden; John Hackett; Barbara Harris; Vera Holzmayer; Ka-Cheung Luk; Gerald Schochetman; Priscilla Swanson; Julie Yamaguchi; Ana Vallari; Nicaise Ndembi; Charlotte Ngansop; Florence Makamche; Dora Mbanya; Lutz G Gürtler; Leopold Zekeng; Lazare Kaptué Journal: J Acquir Immune Defic Syndr Date: 2008-12-01 Impact factor: 3.731
Authors: Michael Worobey; Marlea Gemmel; Dirk E Teuwen; Tamara Haselkorn; Kevin Kunstman; Michael Bunce; Jean-Jacques Muyembe; Jean-Marie M Kabongo; Raphaël M Kalengayi; Eric Van Marck; M Thomas P Gilbert; Steven M Wolinsky Journal: Nature Date: 2008-10-02 Impact factor: 49.962
Authors: Frank A J Konings; Sherri T Burda; Mateusz M Urbanski; Ping Zhong; Arthur Nadas; Phillipe N Nyambi Journal: J Med Virol Date: 2006-05 Impact factor: 2.327
Authors: S Janssen; M A M Huson; S Bélard; S Stolp; N Kapata; M Bates; M van Vugt; M P Grobusch Journal: Infection Date: 2013-12-06 Impact factor: 3.553
Authors: Nuno R Faria; Marc A Suchard; Ana Abecasis; João D Sousa; Nicaise Ndembi; Idalina Bonfim; Ricardo J Camacho; Anne-Mieke Vandamme; Philippe Lemey Journal: Infect Genet Evol Date: 2011-05-04 Impact factor: 3.342
Authors: Cyrille F Djoko; Anne W Rimoin; Nicole Vidal; Ubald Tamoufe; Nathan D Wolfe; Christelle Butel; Matthew LeBreton; Felix M Tshala; Patrick K Kayembe; Jean Jacques Muyembe; Samuel Edidi-Basepeo; Brian L Pike; Joseph N Fair; Wilfred F Mbacham; Karen E Saylors; Eitel Mpoudi-Ngole; Eric Delaporte; Michael Grillo; Martine Peeters Journal: AIDS Res Hum Retroviruses Date: 2010-10-18 Impact factor: 2.205
Authors: Nuno R Faria; Andrew Rambaut; Marc A Suchard; Guy Baele; Trevor Bedford; Melissa J Ward; Andrew J Tatem; João D Sousa; Nimalan Arinaminpathy; Jacques Pépin; David Posada; Martine Peeters; Oliver G Pybus; Philippe Lemey Journal: Science Date: 2014-10-02 Impact factor: 47.728